MedPath
NMPA Approval

Tafluprost and Timolol Maleate Eye Drops

国药准字HJ20250033

Santen Oy

March 25, 2025

Drug Information

他氟噻吗滴眼液

滴眼剂

0.3ml:他氟前列素4.5μg和马来酸噻吗洛尔1.5mg(按C₁₃H₂₄N₄O₃S计)

化学药品

March 25, 2025

March 24, 2030

Company Information

Applicant Company

Santen Oy

Niittyhaankatu 20 33720 Tampere, Finland

Manufacturing Company

1 Rue de I’Arquerie 50200 COUTANCES, FRANCE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

他氟噻吗滴眼液 - NMPA 批准文号 | MedPath